Will seek regulatory approval
Good news for parents worried about sending their kids to school amid the pandemic.
Pfizer announcing today its COVID-19 vaccine works for children ages 5 to 11.
The next step is getting approval from regulators in the U.S.. Britain and Europe to begin with.
Pfizer studied the vaccine in more than 2,000 kindergartners and elementary school-aged kids.
It gave them about a third of the typical dose and found they developed antibody levels just as strong as teens and young adults.

Port Colborne Man Charged with Child Luring
Social Assistance Recipients Receiving Help
Man Faces Multiple Impaired Driving Charges
Police Looking for Stolen Wine
Airport Working to End Sexual Exploitation
Ontario Student Learning Under Review
Senior Seriously Hurt in Parking Lot
Cyclist Seriously Hurt After Collision